Bluesky Facebook Reddit Email

Receipt of buprenorphine and naltrexone for opioid use disorder by race and ethnicity and insurance type

06.26.25 | JAMA Network

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

About The Study: In this cohort study of opioid-related index health care events, race and ethnicity–based and insurance-based disparities in access to medications for opioid use disorder persisted despite efforts to expand treatment availability. These findings underscore the need for targeted interventions, including culturally tailored care, expanded access points, and policy reforms to address structural barriers and reduce inequities contributing to the overdose crisis.

Corresponding Author: To contact the corresponding author, Utsha G. Khatri, MD, MSHP, email utsha.khatri@mountsinai.org .

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.18493)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.18493?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062625

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2025, June 26). Receipt of buprenorphine and naltrexone for opioid use disorder by race and ethnicity and insurance type. Brightsurf News. https://www.brightsurf.com/news/L3RZQKY8/receipt-of-buprenorphine-and-naltrexone-for-opioid-use-disorder-by-race-and-ethnicity-and-insurance-type.html
MLA:
"Receipt of buprenorphine and naltrexone for opioid use disorder by race and ethnicity and insurance type." Brightsurf News, Jun. 26 2025, https://www.brightsurf.com/news/L3RZQKY8/receipt-of-buprenorphine-and-naltrexone-for-opioid-use-disorder-by-race-and-ethnicity-and-insurance-type.html.